Russell Investments Group Ltd. Buys 518,679 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Russell Investments Group Ltd. increased its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBAGet Rating) by 88.9% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 1,101,847 shares of the pharmacy operator’s stock after buying an additional 518,679 shares during the period. Russell Investments Group Ltd. owned 0.13% of Walgreens Boots Alliance worth $34,599,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also modified their holdings of the company. Bank of New Hampshire raised its position in shares of Walgreens Boots Alliance by 56.4% in the 3rd quarter. Bank of New Hampshire now owns 960 shares of the pharmacy operator’s stock valued at $30,000 after buying an additional 346 shares in the last quarter. WFA of San Diego LLC acquired a new position in shares of Walgreens Boots Alliance in the 2nd quarter valued at approximately $32,000. Baystate Wealth Management LLC raised its position in shares of Walgreens Boots Alliance by 209.4% in the 2nd quarter. Baystate Wealth Management LLC now owns 1,216 shares of the pharmacy operator’s stock valued at $46,000 after buying an additional 823 shares in the last quarter. Ronald Blue Trust Inc. acquired a new position in shares of Walgreens Boots Alliance in the 2nd quarter valued at approximately $46,000. Finally, CX Institutional acquired a new position in shares of Walgreens Boots Alliance in the 2nd quarter valued at approximately $47,000. Institutional investors own 56.71% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on WBA. Mizuho lifted their price target on shares of Walgreens Boots Alliance from $36.00 to $41.00 and gave the company a “neutral” rating in a report on Wednesday, December 14th. Cowen raised shares of Walgreens Boots Alliance from a “market perform” rating to an “outperform” rating and lifted their price target for the company from $43.00 to $54.00 in a report on Tuesday, November 22nd. Morgan Stanley reaffirmed an “underweight” rating and set a $39.00 price target on shares of Walgreens Boots Alliance in a report on Wednesday, November 23rd. Truist Financial decreased their price target on shares of Walgreens Boots Alliance from $44.00 to $42.00 and set a “hold” rating on the stock in a report on Thursday, January 19th. Finally, Evercore ISI decreased their price target on shares of Walgreens Boots Alliance from $41.00 to $32.00 and set an “in-line” rating on the stock in a report on Monday, October 3rd. One research analyst has rated the stock with a sell rating, ten have given a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat, Walgreens Boots Alliance has a consensus rating of “Hold” and an average price target of $43.46.

Walgreens Boots Alliance Stock Down 2.1 %

Walgreens Boots Alliance stock opened at $35.90 on Wednesday. The company has a quick ratio of 0.36, a current ratio of 0.70 and a debt-to-equity ratio of 0.32. The firm’s fifty day moving average is $38.86 and its 200 day moving average is $37.22. Walgreens Boots Alliance, Inc. has a 12-month low of $30.39 and a 12-month high of $51.87. The company has a market capitalization of $30.96 billion, a PE ratio of -10.44, a PEG ratio of 1.63 and a beta of 0.75.

Walgreens Boots Alliance (NASDAQ:WBAGet Rating) last posted its quarterly earnings results on Thursday, January 5th. The pharmacy operator reported $1.16 earnings per share for the quarter, beating the consensus estimate of $1.15 by $0.01. The company had revenue of $33.38 billion during the quarter, compared to analyst estimates of $33.04 billion. Walgreens Boots Alliance had a negative net margin of 2.24% and a positive return on equity of 13.57%. The firm’s revenue for the quarter was down 1.5% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.68 earnings per share. As a group, sell-side analysts predict that Walgreens Boots Alliance, Inc. will post 4.5 EPS for the current fiscal year.

Walgreens Boots Alliance Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, December 12th. Investors of record on Tuesday, November 15th were given a dividend of $0.48 per share. The ex-dividend date was Monday, November 14th. This represents a $1.92 annualized dividend and a yield of 5.35%. Walgreens Boots Alliance’s payout ratio is currently -55.81%.

Insiders Place Their Bets

In other Walgreens Boots Alliance news, Director Nancy M. Schlichting sold 16,570 shares of the stock in a transaction dated Thursday, November 17th. The shares were sold at an average price of $39.89, for a total transaction of $660,977.30. Following the completion of the transaction, the director now owns 5,515 shares in the company, valued at $219,993.35. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other news, EVP Kevin M. Ban sold 10,303 shares of the stock in a transaction dated Friday, November 18th. The shares were sold at an average price of $40.19, for a total value of $414,077.57. Following the sale, the executive vice president now directly owns 27,916 shares of the company’s stock, valued at $1,121,944.04. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Nancy M. Schlichting sold 16,570 shares of the stock in a transaction dated Thursday, November 17th. The stock was sold at an average price of $39.89, for a total transaction of $660,977.30. Following the completion of the sale, the director now directly owns 5,515 shares in the company, valued at $219,993.35. The disclosure for this sale can be found here. Company insiders own 17.40% of the company’s stock.

Walgreens Boots Alliance Profile

(Get Rating)

Walgreens Boots Alliance, Inc operates as an integrated healthcare, pharmacy, and retailer in the United States (U.S.), the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores.

Recommended Stories

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.